|
HS Code |
346333 |
| Name | Fraxetin |
| Chemical Formula | C10H8O5 |
| Iupac Name | 7,8-dihydroxy-6-methoxy-2H-chromen-2-one |
| Cas Number | 574-84-5 |
| Appearance | Yellow crystalline powder |
| Solubility In Water | Slightly soluble |
| Melting Point | 180-183°C |
| Source | Found in plants like Fraxinus rhynchophylla |
| Category | Coumarin derivative |
As an accredited Fraxetin factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Fraxetin is packaged in a sealed amber glass vial containing 100 mg, clearly labeled with product name, purity, and safety warnings. |
| Shipping | Fraxetin is shipped in tightly sealed, clearly labeled containers, protected from light and moisture. It complies with applicable chemical transport regulations, ensuring safe handling and storage. The package includes relevant safety documentation, and is typically dispatched via certified carriers, prioritizing prompt, secure delivery with temperature control if required. |
| Storage | Fraxetin should be stored in a cool, dry, and well-ventilated area, away from direct sunlight and sources of heat or ignition. Keep the container tightly sealed when not in use. Store at room temperature, typically between 2–8°C, and avoid exposure to moisture. Ensure proper labeling and keep away from incompatible materials, such as strong oxidizing agents. |
Competitive Fraxetin prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to sales3@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: sales3@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Over the years, our team has produced dozens of phenolic compounds, but few plant-derived products have caught the attention of researchers and customers alike as much as Fraxetin. With a chemical name of 7,8-dihydroxy-6-methoxycoumarin and a structure classified under coumarins, this molecule stands out. Its chemical formula is C10H8O5 and its exact mass sits at 208.0423 g/mol. While coumarins in general offer a wide range of bioactivities, Fraxetin sits among the most studied thanks to its rich history in traditional botanicals and growing recognition in modern science labs. For industrial manufacturers and application developers, this means reliable supply chains, broad technical interest, and opportunities to fine-tune purification and quality assurance processes.
We manufacture Fraxetin in both high purity analytical grade and standard industrial grade. For most research and specialty needs, we offer >98% HPLC-pure Fraxetin as a crystalline yellow powder. Our production system is built to keep moisture below 1.0% and ash well below 0.5%, both determined by stringent process controls. We carefully monitor heavy metals, routinely achieving less than 10 ppm. Every batch undergoes identity confirmation using both HPLC and NMR. Packaging commonly ranges from 1g research vials to kilogram-scale drums, depending on the client's requirements. Every inquiry receives technical backing from our in-house chemists who have worked hands-on with the compound and its transformation at scale, having refined each step from plant extraction or chemical synthesis to crystallization and shipment.
Fraxetin offers broad options for firms interested in exploring plant secondary metabolites. Its most common applications stem from its ability to chelate iron, scavenge free radicals, and block microbial growth. In laboratory research, scientists rely on it both as a reference standard and as a functional agent in comparative work. The pharmaceutical sector investigates Fraxetin for use in anti-inflammatory formulas and therapies targeting certain types of metabolic disorders. Agriculturists and food scientists trial Fraxetin as a plant protectant, exploiting its natural anti-microbial and anti-oxidant effects, especially for improving the shelf life of perishable crops or controlling fungal contamination. Recently, cosmetic formulators have studied it as a potential ingredient in skin-brightening and anti-aging preparations, capitalizing on the evidence for its metal-binding and protective actions at low concentrations.
Working with coumarin derivatives for decades gives us the chance to compare Fraxetin with relatives like esculetin, scopoletin, and fraxin. Structurally, Fraxetin possesses two adjacent hydroxyl groups at the 7 and 8 positions, and a methoxy group at position 6—giving it a capacity for metal ion binding that exceeds most other simple coumarins. This specific arrangement increases its solubility in water and alcohol compared to more hydrophobic relatives. These functional groups also contribute to distinctive chemical reactivity, making Fraxetin more versatile in oxidative or complexation reactions. Where esculetin tends to demonstrate greater free radical quenching, Fraxetin’s chelating ability creates unique interest for applications involving iron overload or heavy metal toxicity. In antimicrobial testing, Fraxetin often outperforms basic coumarins, showing broader inhibition spectra and dose-dependent effects. Many of our customers initially came to us looking for more common coumarins, but after technical consultations and application screening, shifted focus to Fraxetin based on these practical differences.
Producing bulk Fraxetin each year for academic, biotech, and industrial clients gives insight into where quality matters most. Natural sources, chiefly the bark of ash trees and related plants, vary seasonally in their coumarin profiles. Relying strictly on botanical origin would leave buyers exposed to inconsistent levels and potential contaminants. To solve this, we make substantial investments in both botanical raw material sourcing and semi-synthetic processing routes. Each approach has its challenges. Natural extraction runs into limits of yield, sustainability, and contaminant control. Semi-synthetic methods, often starting from umbelliferone, allow for cleaner initial materials and tighter batch-to-batch controls. We run both tracks in parallel and always subject material to full compositional testing and impurity profiling, which protects both our brand and downstream product users from batch failures.
Traceability matters. Each lot carries documented sourcing information, analytical data, and process logs. Regulatory inquiries, or user audits, become routine rather than disruptive, and we encourage clients to request full disclosure of our quality assurance data before purchase. The reality in chemical manufacturing is that even when quality specifications look similar on paper, the critical differences emerge from production discipline and technical support willingness. Over the last ten years, customer returns for Fraxetin have been among our lowest of any plant-derived molecules, and we attribute this to hands-on batch review and technician accountability at every stage.
Fraxetin powders, while chemically stable under ambient storage, can absorb moisture quickly. From experience, direct handling should be minimized, and tightly capped containers must always be used. Glass bottles with PTFE caps stand up best across lab and production environments. Material stored over six months does not show detectable degradation, but we advise field users to recheck product identity if more than one year has elapsed. For dosage, literature suggests wide flexibility based on intended application. Antioxidant trials often use micromolar concentrations, while microbial inhibition experiments use from 10 to 100 µM. Most in vivo research—rodent or cell line-based—favors carefully scaled dosing due to coumarin-related metabolites.
Users planning regulatory submissions benefit from our archived lot data—standard for every product going back over a decade. While Fraxetin is much less hepatotoxic than core coumarin, it should not be used in uncontrolled intake or systemic medicinal formulations without preclinical review. Personal protective equipment, including gloves and mask, remains a must during bulk powder handling in manufacturing or formulation work. On-site training for new staff covers specific chemical safety issues known for coumarin derivatives and builds on our practical experience from both happy customers and rare incident reports.
Interest in Fraxetin shows steady growth. The last few years brought a distinct shift, with fewer requests for basic coumarin and more clients asking directly about less common derivatives with specialized functional benefits. Companies in the nutrition, agriculture, and pharmaceutical sectors increasingly favor multi-functional botanicals over single-purpose ingredients. We expanded our process scale three times in the last eight years, mostly responding to requests for custom batch sizes and tighter impurity controls.
Innovation in application areas comes directly from conversations between technical support and end users. A cosmetics formulator based in France found better stability of their emulsion after switching from esculetin to Fraxetin, thanks to its extra hydroxyl group. An agricultural co-op trialed our Fraxetin in pilot field sprays and reported measurable reduction in post-harvest spoilage compared to standard fungicides. The feedback loop between users and our R&D staff drives us to gather additional application data and refine protocols. We prioritize clients’ direct feedback, especially for new integration suggestions or practical problems with old application methods.
As a manufacturer rooted in both plant-based chemistry and responsible sourcing, we continuously monitor the impact of scaling up Fraxetin production. Ash tree populations face pressure from disease and overharvesting in some regions. We take steps to ensure plant materials come from well-managed or certified sources, often tracing origin to family farms or cooperatives with a documented history. Where possible, we supplement botanical supply with chemically derived intermediates that bypass wild harvesting pressures altogether.
Every year, we conduct audits in partnership with supply chain experts and local NGOs. This effort keeps our inputs aligned with environmental best practices and provides transparency that institutional clients value. On the synthetic front, we review solvent usage and waste output at every stage, updating procedures to adopt green chemistry approaches wherever viable. These steps reflect years of industry listening; a sustainable scale-up matters not just for our planet but also for the long-term credibility and viability of business relationships. Sustainable sourcing remains an ongoing project rather than a solved task, but our experience shows that modest improvements in one season’s procurement cascade into measurable benefits for both community suppliers and downstream users.
Manufacturing Fraxetin at scale puts several technical and operational challenges on the table. Maintaining color, solubility, and purity in each batch calls for both process discipline and technical agility. Process engineers constantly refine crystallization steps to prevent batch yellowing and off-spec purity. Impurities such as residual solvents or trace metabolite byproducts have to be identified and resolved batch by batch, not just by specification sheet. Our lab team uses high-sensitivity chromatographic techniques to screen even minor components. Equipment design, from extractors to filter dryers, goes through periodic review to minimize risk of cross-contamination with other coumarins or plant secondary metabolites.
A recurring challenge comes from variable moisture content in starting plant material—this impacts both extraction yields and downstream drying times. Overcoming this means regularly calibrating equipment and training staff to spot anomalies before they propagate. We invest in vacuum drying and inert gas storage on-site to lock in stability. Every time a process bottleneck appears, we bring together plant managers, chemists, and external QA advisors for joint troubleshooting. Years ago, we faced a run of lots with higher ash content, traced back to a supplier’s change in washing protocol—direct visits and guidance quickly closed the gap. Experience shows that solutions to these problems are rarely technical alone; hands-on engagement with every part of the supply chain delivers reliable, market-ready Fraxetin.
The value of high-quality Fraxetin has unfortunately drawn attention from unscrupulous resellers. Over the last five years, we’ve tracked several instances of adulterated or cut samples appearing in select markets, particularly in fast-growing Asian segments. Buyers sometimes receive material labeled as “Fraxetin” which contains scopoletin or esculetin to increase profit at the margin. To counter this, we invest in regular third-party fingerprinting audits and proactive batch surveillance.
Customers benefit from a transparent supply history, chromatographic purity data, and direct access to our technical team for batch-specific questions. Our sales and logistics staff frequently advise clients on simple in-house tests—such as fluorescence under UV light or color change in iron-complexation assays—that help distinguish authentic Fraxetin from lower-value substitutes. Tracing product from source to shelf is not just a marketing message; it is the only way to guarantee uninterrupted quality and reliability. We encourage open feedback and supply chain vigilance as standard practice. We also publish updates about known market irregularities to help prevent repeat issues in vulnerable markets.
The technical complexity involved in extracting, purifying, and certifying natural products like Fraxetin teaches humility and respect for every stage of the manufacturing process. Reading the latest research only takes an operation so far—real confidence in the product comes from hands-on experience, daily troubleshooting, and years of feedback from critical users. Our staff’s expertise includes not only organic chemistry and process engineering but also plant science and analytical forensics.
Stories from our own production lines often end up shaping both protocol and product development. During one recent campaign, batch testing revealed a suspicious peak on LC-MS chromatograms, traced to a previously unnoticed plant metabolite. Further analysis allowed us to modify the process and raise the purity of finished material above long-standing targets. The experience reinforces the value of technical vigilance and rapid problem-solving. Our chemists, many with years at the bench rather than just in the office, collaborate closely with logistics and quality staff to ensure that theory matches real-world production demands.
Hundreds of academic labs use our Fraxetin for basic mechanistic work, while a small but growing number of pharmaceutical innovators design new formulations based on its biochemical signatures. One biotech client used Fraxetin as a chelation agent in lead detoxification protocols for animal models. A nutraceutical formulator created an antioxidant blend where Fraxetin acts synergistically with flavonoids from berries, and preliminary results suggest a meaningful boost in activity compared to their original formula. In agricultural circles, Fraxetin sometimes finds its way into experimental seed coatings, aimed at managing metal stress in field soil.
Supporting this work requires more than technical data. Fielding complex inquiries, providing COA (certificate of analysis), and collaborating on custom batch requests plays a major role in how quickly new product concepts move from benchtop to real-world rollout. We recognize that successful innovation rarely follows a straight path—most project timelines involve pivots, formulation changes, and unanticipated analytical hurdles. Our commitment to supporting innovation does not mean one-size-fits-all service or endless paperwork; it means understanding customer goals and providing targeted technical solutions, troubleshooting support, and clear communication as needs evolve.
As demand for botanical ingredients grows, so does regulatory scrutiny and consumer expectation around transparency, safety, and environmental impact. Our experiences scaling Fraxetin production have made clear that compliance demands proactive investment—not just in analytics, but in workforce training, sustainable procurement, risk monitoring, and ongoing dialogue with clients and partners.
Efforts already underway include modernizing extraction facilities to cut solvent use and emissions, developing new semi-synthetic pathways that bypass slow or costly supply chains, and backing applied research to explore additional uses for Fraxetin in health, agriculture, and materials science. Growth in the field hinges on direct relationships—between manufacturer and supplier; supplier and formulator; technical staff and regulatory bodies—and on the humility to adapt process and protocol in response to new challenges.
In the end, Fraxetin’s market potential rests not just on chemical uniqueness, but on the hard work, attention to detail, and partnership that come with every order. Our ongoing mission is to support those who trust in this compound as part of their innovation journey, and to improve, step by step, how Fraxetin is sourced, handled, processed, and delivered to every lab and plant floor that calls on it.